Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion type Assertion NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_head.
- NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion description "[Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_provenance.
- NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion evidence source_evidence_literature NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_provenance.
- NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion SIO_000772 25725586 NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_provenance.
- NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion wasDerivedFrom befree-2016 NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_provenance.
- NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_assertion wasGeneratedBy ECO_0000203 NP1267065.RAHOUE8GynAa3U0W2EmtQEI2_4e3VEI3j1CQkHRqA1ECw130_provenance.